Vapotherm, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-09-20: Form 8-K; Period of report 2024-09-20; Description 2.01 Completion of Acquisition or Disposition of Assets; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 2.01.
- 2024-09-19: Form 8-K; Period of report 2024-09-19; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2024-08-12: Form 8-K; Period of report 2024-08-12; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2024-06-20: Form 8-K; Period of report 2024-06-17; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2024-09-20 | 8-K | 2024-09-20 | 2.01 Completion of Acquisition or Disposition of Assets; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 2.01 The information set forth in the Introduction of this Current Report on Form 8-K (the “Introduction”) is incorporated by reference into this Item 2.01. 3.01 The information set forth in the Introduction is incorporated by reference into this Item 3.01. 3.02 On September 20, 2024, immediately prior to the contributions described above under Item 2.01 under the heading “SLR Rollover Agreements and Warrant Amendment” and pursuant to the terms of the Warrant Amendment, the Company issued all of the remaining Warrants required to be issued to the SLR Warrant Holders under the terms of the Loan and Security Agreement. 3.03 The information set forth in the Introduction and under Item 2.01 and Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03. 5.01 The information set forth in the Introduction and under Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.01. 5.02 In connection with the consummation of the Merger and in accordance with the Merger Agreement (and not as a result of any disagreement with the Company), the following directors of the Company resigned and ceased to be directors of the Company as of the Effective Time: Joseph Army, Anthony Arnerich, Lance Berry, Lori Knowles, James Liken, Mary Beth Moynihan, Donald Spence and Elizabeth Weatherman. 5.03 At the Effective Time, (i) the Company’s certificate of incorporation was amended and restated in its entirety and (ii) the Company’s bylaws were amended and restated in their entirety, each in accordance with the terms of the Merger Agreement and the DGCL. 8.01 On September 20, 2024, the Company issued a press release announcing the closing of the Merger, which press release is filed as Exhibit 99.1 hereto and incorporated herein by reference. | vapo20240916c_8k.htm |
| 2024-09-19 | 8-K | 2024-09-19 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Vapotherm, Inc., a Delaware corporation (the “Company”), held a special meeting of stockholders on September 19, 2024 (the “Special Meeting”) to consider certain proposals related to the Agreement and Plan of Merger, dated as of June 17, 2024 (the “Merger Agreement”), by and among Veronica Holdings, LLC, a Delaware limited liability company (“Topco”), Veronica Intermediate Holdings, LLC, a Delaware limited liability company and wholly owned subsidiary of Topco (“Parent”), Veronica Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and the Company, pursuant to which, among other things, Merger Sub will merge with and into the Company (the “Merger”), and as a result of which the separate corporate existence of Merger Sub will cease, and the Company will continue as the surviving corporation of the Merger and as a direct, wholly owned subsidiary of Parent. | vapo20240916_8k.htm |
| 2024-08-12 | 8-K | 2024-08-12 | 2.02 Results of Operations and Financial Condition | 2.02 On August 12, 2024, Vapotherm, Inc. (the “Company”) announced its financial results for the second quarter ended June 30, 2024. | vapo-20240812.htm |
| 2024-06-20 | 8-K | 2024-06-17 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 2.03 The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03. 5.02 On June 17, 2024, the Company’s President and Chief Executive Officer (“CEO”) entered into a side letter with the Company pursuant to which, among other things, the CEO agreed to waive his enhanced severance under the terms of his separation pay agreement with the Company, dated March 24, 2022, in connection with the consummation of the Merger. | vapo20240616_8k.htm |
| 2024-05-09 | 8-K | 2024-05-09 | 2.02 Results of Operations and Financial Condition | 2.02 On May 9, 2024, Vapotherm, Inc. (the “Company”) announced its financial results for the first quarter ended March 31, 2024. | vapo-20240509.htm |
| 2024-04-01 | 8-K | 2024-03-26 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 2.03 The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03. 7.01 The information contained in this Item 7.01 is deemed to have been furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act. | vapo-20240326.htm |
| 2024-02-27 | 8-K | 2024-02-26 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 26, 2024, the Board of Directors (the “Board”) of Vapotherm, Inc. (the “Company”), upon recommendation of the Compensation Committee of the Board (the “Compensation Committee”), approved a stock option repricing, effective February 27, 2024, where the exercise price of all outstanding options to purchase shares of the Company’s common stock (the “Common Stock”), other than options held by non-employee Board members, was reduced to $0.915 per share, the closing price of the Common Stock on February 27, 2024 (the “Option Repricing”). | vapo-20240226.htm |
| 2024-02-22 | 8-K | 2024-02-22 | 2.02 Results of Operations and Financial Condition | 2.02 On February 22, 2024, Vapotherm, Inc. (the “Company”) announced its financial results for the fourth quarter and year ended December 31, 2023. | vapo-20240222.htm |
| 2023-12-15 | 8-K | 2023-12-14 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On December 14, 2023, Vapotherm, Inc. (the “Company”) received a letter from the staff of New York Stock Exchange (“NYSE”) Regulation notifying the Company that it had determined to commence proceedings to delist the Company’s common stock (NYSE: VAPO) from the NYSE. | vapo-20231214.htm |
| 2023-12-11 | 8-K | 2023-12-07 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On December 11, 2023, Vapotherm, Inc. (the “Company”) announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and its filing of an application to have its common stock quoted on the OTCQX Marketplace (“OTCQX”). | vapo-20231207.htm |
| 2023-11-08 | 8-K | 2023-11-08 | 2.02 Results of Operations and Financial Condition | 2.02 On November 8, 2023, Vapotherm, Inc. (the “Company”) announced its financial results for the third quarter ended September 30, 2023. | vapo-20231108.htm |
| 2023-10-02 | 8-K | 2023-09-26 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 5.02 On September 26, 2023, Vapotherm, Inc. (the “Company”) and its Chief Commercial Officer, Gregoire Ramade, mutually agreed to an amicable separation of employment, effective October 31, 2023. 7.01 The Company reiterates its most recent full year 2023 revenue guidance of between $70 million and $73 million. | vapo-20230926.htm |
| 2023-08-17 | 8-K | 2023-08-17 | 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 3.03 To the extent required by Item 3.03 of Form 8-K, the information set forth under Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03. 5.03 On August 17, 2023, Vapotherm, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Tenth Amended and Restated Certificate of Incorporation (the “Charter Amendment”) to effect a 1-for-8 reverse stock split of the Company’s common stock and a corresponding reduction in its authorized shares of common stock, effective as of 12:01 a.m., Eastern Time, on August 18, 2023 (the “Effective Time”). | d530849d8k.htm |
| 2023-08-08 | 8-K | 2023-08-08 | 2.02 Results of Operations and Financial Condition; 8.01 Other Events | 2.02 On August 8, 2023, Vapotherm, Inc. (the “Company”) announced its financial results for the second quarter ended June 30, 2023. 8.01 As previously announced, on July 20, 2023, at an annual meeting of stockholders, the Company’s stockholders approved an amendment to the Company’s Tenth Amended and Restated Certificate of Incorporation, as amended, to give the Board of Directors discretion to effect a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of between 1-for-3 and 1-for-8, inclusive, such ratio, and the decision to effect the reverse split, to be determined by the Board of Directors in its sole discretion. | vapo-20230808.htm |
| 2023-06-21 | 8-K | 2023-06-20 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Vapotherm, Inc. (the “Company”) held its annual meeting of stockholders on June 20, 2023 (the “2023 Annual Meeting”). | vapo-20230620.htm |
| 2023-05-03 | 8-K | 2023-05-03 | 2.02 Results of Operations and Financial Condition | 2.02 On May 3, 2023, Vapotherm, Inc. announced its financial results for the first quarter ended March 31, 2023. | vapo-20230503.htm |
| 2023-03-17 | 8-K | 2023-03-15 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 7.01 Regulation FD Disclosure | 3.01 On March 15, 2023, Vapotherm, Inc. (the “Company”) received a notice (the “Notice”) from the New York Stock Exchange, Inc. (the “NYSE”) that the Company is not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period. 7.01 On March 17, 2023, the Company issued a press release announcing its receipt of the Notice. | vapo-20230315.htm |
| 2023-03-10 | 8-K | 2023-03-10 | 7.01 Regulation FD Disclosure | 7.01 Vapotherm, Inc. informs its investors that it does not hold cash deposits or securities at Silicon Valley Bank. | d451039d8k.htm |
| 2023-02-23 | 8-K | 2023-02-23 | 2.02 Results of Operations and Financial Condition | 2.02 On February 23, 2023, Vapotherm, Inc. announced its financial results for the fourth quarter and the full year ended December 31, 2022. | vapo-20230223.htm |
| 2023-02-16 | 8-K | 2023-02-10 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 2.03 The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03. 7.01 The information contained in this Item 7.01 is deemed to have been furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act. | vapo-20230210.htm |
| 2023-02-14 | 8-K | 2023-02-08 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On February 8, 2023, the Board of Directors (the “Board”) of Vapotherm, Inc. (the “Company”) approved and adopted Second Amended and Restated Bylaws (the “Amended and Restated Bylaws”) incorporating certain amendments, including amendments in response to the new universal proxy rules promulgated by the Securities and Exchange Commission (the “SEC”) and recent amendments to the Delaware General Corporation Law (the “DGCL”). | vapo-20230208.htm |
| 2023-02-08 | 8-K | 2023-02-07 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 3.02 To the extent required by Item 3.02 of Form 8-K, the information regarding the Common Stock and Warrants set forth under Item 1.01 of this Form 8-K is incorporated by reference in this Item 3.02. 7.01 On February 8, 2023, the Company issued a press release announcing the Purchase Agreement. | vapo-20230207.htm |
| 2023-02-08 | 8-K | 2023-02-08 | 2.02 Results of Operations and Financial Condition | 2.02 On February 8, 2023, Vapotherm, Inc. (the “Company”) issued a press release announcing preliminary and unaudited fourth quarter and full year 2022 financial results. | vapo-20230208.htm |
| 2022-12-06 | 8-K | 2022-11-30 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 7.01 Regulation FD Disclosure | 3.01 On November 30, 2022, Vapotherm, Inc. (the “Company”) received a notice (the “Notice”) from the New York Stock Exchange, Inc. (the “NYSE”) that the Company is not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period. 7.01 On December 6, 2022, the Company issued a press release announcing its receipt of the Notice. | vapo-20221130.htm |
| 2022-11-22 | 8-K | 2022-11-22 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 7.01 Regulation FD Disclosure | 1.01 On November 22, 2022 (the “Effective Date”), Vapotherm, Inc. (the “Company”) entered into an Amendment No. 3 to Loan and Security Agreement with SLR Investment Corp., as Collateral Agent, and the lenders party thereto (the “Third Amendment,” together with the Loan and Security Agreement, the “Amended Loan and Security Agreement”). 2.03 The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03. 7.01 On November 22, 2022, the Company issued a press release announcing the Third Amendment. | d423415d8k.htm |
| 2022-11-02 | 8-K | 2022-11-02 | 2.02 Results of Operations and Financial Condition | 2.02 On November 2, 2022, Vapotherm, Inc. announced its financial results for the third quarter ended September 30, 2022. | vapo-20221102.htm |
| 2022-10-03 | 8-K | 2022-09-27 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 7.01 Regulation FD Disclosure | 1.01 On September 30, 2022 (the “Effective Date”), Vapotherm, Inc. (the “Company”) entered into an Amendment No. 2 to Loan and Security Agreement with SLR Investment Corp., as Collateral Agent, and the lenders party thereto (the “Second Amendment,” together with the Loan and Security Agreement, the “Amended Loan and Security Agreement”). 2.03 The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03. 3.01 On September 27, 2022, the Company received a notice (the “Notice”) from the New York Stock Exchange, Inc. (the “NYSE”) that the Company is not in compliance with the continued listing standards set forth in Section 802.01B of the NYSE Listed Company Manual. 7.01 On October 3, 2022, the Company issued a press release announcing the Second Amendment and its receipt of the Notice from the NYSE. | vapo-20220927.htm |
| 2022-08-03 | 8-K/A | 2022-04-27 | 2.05 Costs Associated with Exit or Disposal Activities | 2.05 On April 27, 2022, Vapotherm, Inc. (the “Company”) committed to a plan to relocate all of its manufacturing operations from Exeter, New Hampshire to a company operated manufacturing facility in Mexico to be determined. | vapo-20220427.htm |
| 2022-08-03 | 8-K | 2022-08-03 | 2.02 Results of Operations and Financial Condition | 2.02 On August 3, 2022, Vapotherm, Inc. announced its financial results for the second quarter ended June 30, 2022. | vapo-20220803.htm |
| 2022-07-11 | 8-K | 2022-07-08 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The information included in Item 1.01 of this Current Report on Form 8-K is incorporated into this Item 2.03 of this Current Report on Form 8-K by reference. | vapo-20220708.htm |
| 2022-06-22 | 8-K | 2022-06-21 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Vapotherm, Inc. (the “Company”) held its annual meeting of stockholders on June 21, 2022 (the “2022 Annual Meeting”). | vapo-20220621.htm |
| 2022-06-03 | 8-K | 2022-05-27 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | vapo-20220527.htm |
| 2022-05-04 | 8-K | 2022-05-04 | 2.02 Results of Operations and Financial Condition | 2.02 On May 4, 2022, Vapotherm, Inc. announced its financial results for the first quarter of March 31, 2022. | vapo-20220504.htm |
| 2022-04-12 | 8-K | 2022-04-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On April 6, 2022, Vapotherm, Inc. (the “Company”) entered into a separation pay agreement with each of the Company’s President and Chief Executive Officer (“CEO”), Senior Vice President and Chief Financial Officer (“CFO”) and Senior Vice President and Chief Commercial Officer (“CCO”), replacing the existing severance protections for the CEO and CFO. | vapo-20220412.htm |
| 2022-04-06 | 8-K | 2022-04-06 | 2.02 Results of Operations and Financial Condition | 2.02 On April 6, 2022, Vapotherm, Inc. (the "Company") issued a press release announcing preliminary and unaudited first quarter 2022 revenue results. | vapo-20220406.htm |
| 2022-02-24 | 8-K | 2022-02-24 | 2.02 Results of Operations and Financial Condition | 2.02 On February 24, 2022, Vapotherm, Inc. announced its financial results for the fourth quarter and the full year ended on December 31, 2021. | vapo-8k_20220224.htm |
| 2022-01-12 | 8-K | 2022-01-12 | 2.02 Results of Operations and Financial Condition | 2.02 On January 12, 2022, Vapotherm, Inc. (the “Company”) issued a press release announcing preliminary and unaudited fourth quarter and full year 2021 revenue results. | vapo-8k_20220112.htm |
| 2022-01-04 | 8-K | 2022-01-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 In order to better align CEO compensation with the interests of stockholders, the Compensation Committee of the Board of Directors of Vapotherm, Inc. (the “Company”) has elected to award 100% of the CEO’s 2022 annual equity grant in the form of three-year performance stock units (“PSUs”). | d265482d8k.htm |
| 2021-12-06 | 8-K | 2021-12-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 5.02 On December 6, 2021, Vapotherm announced the appointment of Dorota McKay as Controller and Chief Accounting Officer, effective immediately. 7.01 On December 6, 2021, Vapotherm, Inc. (“Vapotherm”) announced the appointment of Brian Lawrence as Senior Vice President and Chief Technology Officer, effective immediately. | vapo-8k_20211206.htm |
| 2021-11-03 | 8-K | 2021-11-03 | 2.02 Results of Operations and Financial Condition | 2.02 On November 3, 2021, Vapotherm, Inc. announced its financial results for the third quarter ended on September 30, 2021. | vapo-8k_20211103.htm |
| 2021-09-27 | 8-K | 2021-09-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 21, 2021, Joel Dube notified Vapotherm, Inc. (the “Company”) of his decision to resign as Chief Accounting Officer of the Company effective October 6, 2021 in order to pursue other career opportunities. | vapo-8k_20210921.htm |
| 2021-08-09 | 8-K | 2021-08-09 | 2.02 Results of Operations and Financial Condition | 2.02 On August 9, 2021, Vapotherm, Inc. announced its financial results for the second quarter ended on June 30, 2021. | vapo-8k_20210809.htm |
| 2021-06-24 | 8-K | 2021-06-22 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 At the annual meeting of stockholders of Vapotherm, Inc. (the “Company”) held on June 22, 2021 (the “2021 Annual Meeting”), the Company’s stockholders elected each of Lori Knowles and Mary Beth Moynihan as a new Class III director of the Company effective immediately. 5.07 As mentioned above, the Company held its 2021 Annual Meeting on June 22, 2021. | vapo-8k_20210622.htm |
| 2021-05-05 | 8-K | 2021-05-05 | 2.02 Results of Operations and Financial Condition | 2.02 On May 5, 2021, Vapotherm, Inc. announced its financial results for the first quarter ended on March 31, 2021. | vapo-8k_20210505.htm |
| 2021-02-24 | 8-K | 2021-02-24 | 2.02 Results of Operations and Financial Condition | 2.02 On February 24, 2021, Vapotherm, Inc. announced its financial results for the fourth quarter and the full year ended on December 31, 2020. | vapo-8k_20210224.htm |
| 2021-01-13 | 8-K | 2021-01-13 | 7.01 Regulation FD Disclosure | 7.01 On January 13, 2021, Vapotherm, Inc. (the “Company”) issued a press release providing an update to its fourth quarter and fiscal year 2020 revenue guidance given on December 1, 2020. | vapo-8k_20210113.htm |
| 2020-12-01 | 8-K | 2020-12-01 | 7.01 Regulation FD Disclosure | 7.01 On December 1, 2020, Vapotherm, Inc. (the “Company”) issued a press release providing an update to its fourth quarter and fiscal year 2020 revenue guidance given on November 4, 2020. | vapo-8k_20201201.htm |
| 2020-11-04 | 8-K | 2020-11-04 | 2.02 Results of Operations and Financial Condition | 2.02 On November 4, 2020, Vapotherm, Inc. announced its financial results for the fiscal 2020 third quarter ended on September 30, 2020. | vapo-8k_20201104.htm |
| 2020-10-23 | 8-K | 2020-10-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 In connection with certain organizational adjustments, Gregoire Ramade, formerly Vice President, International Sales and Worldwide Marketing of Vapotherm, Inc. (the “Company”), was promoted to the position of Senior Vice President, Chief Commercial Officer of the Company. | vapo-8k_20201021.htm |
| 2020-10-22 | 8-K | 2020-10-21 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 1.02 On October 21, 2020, the Company used approximately $40 million of the Term Facility, approximately $4.9 million of the Revolving Facility and approximately $5.7 million of cash on hand to pay off all obligations owing under, and to terminate, both the Credit Agreement and Guarantee dated as of April 6, 2018 by and between Perceptive Credit Holdings II, L.P. and the Company, and the Amended and Restated Business Financing Agreement dated as of April 6, 2018 by and between Western Alliance Bank and the Company. 2.03 To the extent required by Item 2.03 of Form 8-K, the information regarding the Revolving Facility and the Term Facility set forth under Item 1.01 of this Form 8-K is incorporated by reference in this Item 2.03. 7.01 On October 22, 2020, the Company issued a press release announcing the execution of the Loan Agreement. | vapo-8k_20201021.htm |
| 2020-10-02 | 8-K | 2020-09-29 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03. | vapo-8k_20200929.htm |
| 2020-08-04 | 8-K | 2020-08-04 | 2.02 Results of Operations and Financial Condition | 2.02 On August 4, 2020, Vapotherm, Inc. announced its financial results for the fiscal 2020 second quarter ended on June 30, 2020. | vapo-8k_20200804.htm |
| 2020-06-24 | 8-K | 2020-06-23 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders | 5.03 At the annual meeting of stockholders held on June 23, 2020 (the “2020 Annual Meeting”), Vapotherm, Inc.’s (the “Company”) stockholders voted to approve an amendment to the Company’s Tenth Amended and Restated Certificate of Incorporation (“Charter”) to add a federal forum selection clause, which provides that unless the Company’s board of directors consents in writing to the selection of an alternate forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any claim arising under the Securities Act of 1933, as amended. 5.07 At the 2020 Annual Meeting, the Company’s stockholders voted on the following proposals, each of which is described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on May 1, 2020. | vapo-8k_20200623.htm |
| 2020-05-11 | 8-K | 2020-05-06 | 8.01 Other Events | 8.01 On May 6, 2020, Vapotherm, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with BofA Securities, Inc. and William Blair & Company, L.L.C., as representatives of the several underwriters named in Schedule A thereto (the “Underwriters”) relating to the underwritten offering of 3,350,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Offering”). | d927843d8k.htm |
| 2020-05-05 | 8-K | 2020-05-05 | 2.02 Results of Operations and Financial Condition | 2.02 On May 5, 2020, Vapotherm, Inc. announced its financial results for the fiscal 2020 first quarter ended on March 31, 2020. | vapo-8k_20200505.htm |
| 2020-04-13 | 8-K | 2020-04-13 | 2.02 Results of Operations and Financial Condition; 8.01 Other Events | 2.02 On April 13, 2020, Vapotherm, Inc. (“Vapotherm”) issued a press release providing approximate revenue results and gross margins for the fiscal 2020 first quarter and expected cash and cash equivalents as of the end of the fiscal 2020 first quarter. 8.01 As a result of the global outbreak of the novel coronavirus (COVID-19), Vapotherm is filing this Current Report on Form 8-K in order to update its risk factor disclosure titled A pandemic, epidemic or outbreak of an infectious disease, such as the coronavirus, or COVID-19, may adversely affect our business in Item 1A of its Annual Report on Form 10-K for the fiscal year ended December 31, 2019 as filed with the Securities and Exchange Commission on March 4, 2020 under the heading “Risk Factors - Risks Related to our Business”. | vapo-8k_20200120.htm |
| 2020-03-04 | 8-K | 2020-03-04 | 2.02 Results of Operations and Financial Condition | 2.02 On March 4, 2020, Vapotherm, Inc. announced its financial results for the fiscal 2019 fourth quarter and the full fiscal year ended on December 31, 2019. | vapo-8k_20200312.htm |
| 2020-01-30 | 8-K | 2020-01-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On January 28, 2020, Neal Armstrong notified Vapotherm, Inc. (the “Company”) of his respective decision to resign from the Board of Directors of the Company (the “Board”) and as a member and the chair of the Audit Committee of the Company (the “Audit Committee”) effective January 29, 2020. | vapo-8k_20200128.htm |
| 2020-01-10 | 8-K | 2020-01-10 | 2.02 Results of Operations and Financial Condition | 2.02 On January 10, 2020, Vapotherm, Inc. issued a press release providing approximate revenue results for the fiscal 2019 fourth quarter and full fiscal 2019 year. | vapo-8k_20200113.htm |
| 2019-11-05 | 8-K | 2019-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2019, Vapotherm, Inc. announced its financial results for the fiscal 2019 third quarter. | vapo-8k_20191105.htm |
| 2019-07-29 | 8-K | 2019-07-29 | 2.02 Results of Operations and Financial Condition | 2.02 On July 29, 2019, Vapotherm, Inc. announced its financial results for the fiscal 2019 second quarter. | vapo-8k_20190729.htm |
| 2019-06-19 | 8-K | 2019-06-18 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 At the annual meeting of stockholders held on June 18, 2019, Vapotherm, Inc.’s (the “Company”) stockholders voted on the following proposals, each of which is described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 24, 2019. | vapo-8k_20190618.htm |
| 2019-05-07 | 8-K | 2019-05-07 | 2.02 Results of Operations and Financial Condition | 2.02 On May 7, 2019, Vapotherm, Inc. announced its financial results for the fiscal 2019 first quarter. | vapo-8k_20190507.htm |
| 2019-03-12 | 8-K | 2019-03-12 | 2.02 Results of Operations and Financial Condition | 2.02 On March 12, 2019, Vapotherm, Inc. announced its financial results for the fiscal 2018 fourth quarter and the full fiscal year ended on December 31, 2018. | ck0001253176-8k_20190312.htm |
| 2018-11-20 | 8-K | 2018-11-16 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On November 16, 2018, and in connection with the consummation of Vapotherm, Inc.’s (the “Company”) initial public offering of its common stock (the “IPO”), the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware. | d641554d8k.htm |